Who owns AAVantgarde Bio?

AAVantgarde Bio is currently owned by Sofinnova Partners, through Sofinnova Telethon, since 2020.

When did Sofinnova Partners acquire AAVantgarde Bio?

Sofinnova Partners acquired AAVantgarde Bio in 2020 (active for 6 years).

Home/Companies/Biotech/AAVantgarde Bio

AAVantgarde Bio

Biotech·

Italy·Active·6yr hold

AAVantgarde Bio is a healthcare / biotech company, headquartered in Italy.

Entry

2020

Hold

6yr

Status

Active

Est. EV

–

Investor

Sofinnova Partners

Key facts

HQItaly

SectorHealthcare / Biotech

Italian gene therapy company developing AAV-based treatments for inherited retinal disorders including Stargardt disease.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from Sofinnova Telethon

Other portfolio companies in the same fund.

nChroma (formerly Chroma Medicine)

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Last updated April 2026 · Sourced from public filings